Simulation study of methemoglobin reduction in erythrocytes - Differential contributions of two pathways to tolerance to oxidative stress

被引:52
作者
Kinoshita, Ayako
Nakayama, Yoichi [1 ]
Kitayama, Tomoya
Tomita, Masaru
机构
[1] Keio Univ, Inst Adv Biosci, Fujisawa, Kanagawa 2528520, Japan
[2] Articell Syst Corp, Network Biol Res Ctr, Fujisawa, Kanagawa, Japan
关键词
erythrocyte; mathematical modeling; metabolism; methemoglobin; oxidative stress;
D O I
10.1111/j.1742-4658.2007.05685.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Methemoglobin (metHb), an oxidized form of hemoglobin, is unable to bind and carry oxygen. Erythrocytes are continuously subjected to oxidative stress and nitrite exposure, which results in the spontaneous formation of metHb. To avoid the accumulation of metHb, reductive pathways mediated by cytochrome b5 or flavin, coupled with NADH-dependent or NADPH-dependent metHb reductases, respectively, keep the level of metHb in erythrocytes at less than 1% of the total hemoglobin under normal conditions. In this work, a mathematical model has been developed to quantitatively assess the relative contributions of the two major metHb-reducing pathways, taking into consideration the supply of NADH and NADPH from central energy metabolism. The results of the simulation experiments suggest that these pathways have different roles in the reduction of metHb; one has a high response rate to hemoglobin oxidation with a limited reducing flux, and the other has a low response rate with a high capacity flux. On the basis of the results of our model, under normal oxidative conditions, the NADPH-dependent system, the physiological role of which to date has been unclear, is predicted to be responsible for most of the reduction of metHb. In contrast, the cytochrome b5-NADH pathway becomes dominant under conditions of excess metHb accumulation, only after the capacity of the flavin-NADPH pathway has reached its limit. We discuss the potential implications of a system designed with two metHb-reducing pathways in human erythrocytes.
引用
收藏
页码:1449 / 1458
页数:10
相关论文
共 50 条
[1]   PROPERTIES OF CYTOCHROME-B5 AND METHEMOGLOBIN REDUCTION IN HUMAN-ERYTHROCYTES [J].
ABE, K ;
SUGITA, Y .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1979, 101 (02) :423-428
[2]   Redox modifications of protein-thiols: Emerging roles in cell signaling [J].
Biswas, S ;
Chida, AS ;
Rahman, I .
BIOCHEMICAL PHARMACOLOGY, 2006, 71 (05) :551-564
[3]   METHEMOGLOBIN AND ITS REDUCTION IN NUCLEATED ERYTHROCYTES FROM REPTILES AND BIRDS [J].
BOARD, PG ;
AGAR, NS ;
GRUCA, M ;
SHINE, R .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1977, 57 (03) :265-267
[4]   An erythroid-specific transcript generates the soluble form of NADH-cytochrome b5 reductase in humans [J].
Bulbarelli, A ;
Valentini, A ;
De Silvestris, M ;
Cappellini, MD ;
Borgese, N .
BLOOD, 1998, 92 (01) :310-319
[5]   The redox switch/redox coupling hypothesis [J].
Cerdán, S ;
Rodrigues, TB ;
Sierra, A ;
Benito, M ;
Fonseca, LL ;
Fonseca, CP ;
García-Martín, ML .
NEUROCHEMISTRY INTERNATIONAL, 2006, 48 (6-7) :523-530
[6]   Initial-rate kinetics of the flavin reductase reaction catalysed by human biliverdin-IXβ reductase (BVR-B) [J].
Cunningham, O ;
Gore, MG ;
Mantle, TJ .
BIOCHEMICAL JOURNAL, 2000, 345 :393-399
[7]   METHEMOGLOBINEMIA [J].
CURRY, S .
ANNALS OF EMERGENCY MEDICINE, 1982, 11 (04) :214-221
[8]  
Desagher S, 1997, J NEUROSCI, V17, P9060
[10]  
Grimes A.J., 1980, HUMAN RED CELL METAB